ALEMBIC PHARMA Q2 FY27 ; NET PROFIT UP 81% AT ₹335 CR (YOY), UP 94% (QOQ)

REVENUE UP 36% AT ₹2,603 CR (YOY), UP 21% (QOQ) EBITDA UP 78% AT ₹563 CR (YOY), UP 70% (QOQ) MARGINS AT 21.6% VS 16.5% (YOY), 15.4% (QOQ)

ALEMBIC PHARMA LTD